Arkolith/Insider Trading/RYZB/Form 4

Moran Susan

CHIEF MEDICAL OFFICERRayzeBio, Inc. (RYZB) · full profile →Form 4 · filed Feb 27, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2024Disposed to issuer(D)323K$62.50$20.2M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2024Disposed to issuer(D)164K——0
Feb 26, 2024Disposed to issuer(D)78K——0
Feb 26, 2024Disposed to issuer(D)61K——0
Feb 26, 2024Disposed to issuer(D)195K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-005507) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML